REGULATORY

• Drug Makers Should Join in “Concerted National Effort” to Propel Regulatory Harmonization in Asia: Ex-PMDA Chair
  April 27, 2020

• Japan Moving to Thwart Foreign Takeover of Drug, Medical Devices Makers
  April 24, 2020

• In a First, Chuikyo to Be Streamed Live amid COVID-19 Outbreak
  April 23, 2020

• Japan to Make Drug Review Time as Short as Possible for COVID-19: Minister
  April 22, 2020

• Novartis’ Entresto, Mayzent Up for MHLW Panel Review in Round Robin Method
  April 20, 2020

• Japan Declares Nationwide State of Emergency
  April 17, 2020

• MSD’s 9-Valent HPV Vaccine Up for Review in 1st Online PAFSC Meeting
  April 16, 2020

• Novartis’ Flawed and Delayed Inquiry Responses in Zolgensma Review “Extremely Unusual”: PMDA Report
  April 16, 2020

• Osaka Pref., Osaka Univ. Form Alliance for COVID-19 Vaccine; AnGes Clinical Study Planned as Early as July
  April 16, 2020

• MHLW Asks Drug Makers, Wholesalers to Reduce People Coming to Work by “at Least 70%”
  April 15, 2020

• Health Minister Vows to Shorten Review Time for Avigan
  April 14, 2020

• MSD’s 9-Valent HPV Vaccine Nearing Finish Line in Japan 5 Years after Filing, but Vaccination Policy Remains Iffy
  April 13, 2020

• 15 Insulins, Erleada, Faslodex under PMDA Safety Review
  April 13, 2020

• MHLW Urges Drug Makers, Wholesalers to Ensure Stable Drug Supplies amid Emergency
  April 10, 2020

• MHLW Plans to Revise National Vaccine Certification Rules in June
  April 10, 2020

• League of Lawmakers Urges MHLW to Help COVID-19 Drug/Vaccine Development
  April 10, 2020

• Chuikyo Allows Round Robin Meetings for Coronavirus-Related Matters
  April 9, 2020

• Should Japan Go Ahead with Off-Year Re-Pricing amid COVID-19 Outbreak? Chuikyo Members Want It Discussed
  April 9, 2020

• PMDA to Accept Trial Notifications by Email amid Coronavirus Outbreak
  April 9, 2020

• MHLW Staffer Infected with Novel Coronavirus
  April 9, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 182
• 183
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• …
• Next ›
• 最終 »